Related Experiment Video
Updated: Aug 6, 2026

Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
Pyrazole-Derived Antibacterial Compounds Effectively Treat Methicillin-Resistant Staphylococcus Aureus Infections by
Xiaorong Yang1, Xinyuan Cao2,3, Lixia Dai1,4
1Key Laboratory of New Animal Drug Project, Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Key Laboratory of Veterinary Pharmaceutical Development of Ministry of Agriculture, Chinese Academy of Agricultural Sciences, Lanzhou, Gansu, P. R. China.
A new pyrazole compound, Py-27, effectively kills methicillin-resistant Staphylococcus aureus (MRSA) by inhibiting aspartate transcarbamoylase (ATCase). This novel approach shows promise for treating persistent MRSA infections with low resistance potential.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Biochemistry
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat, necessitating novel antimicrobial strategies.
- Existing treatments face challenges due to increasing resistance, highlighting the urgent need for new therapeutic agents with unique mechanisms of action.
Purpose of the Study:
- To discover and characterize novel compounds with bactericidal activity against MRSA.
- To identify the molecular target and elucidate the mechanism of action for newly discovered MRSA-targeting compounds.
Main Methods:
- Chemoproteomic screening to identify compound targets.
- Biophysical and enzymatic assays to confirm target engagement and inhibition.
- Genetic manipulation (knockout studies) to validate target essentiality.
- In vitro biofilm eradication assays.
- In vivo efficacy studies in animal infection models.
Main Results:
- Py-27, a pyrazole-derived compound, demonstrated potent bactericidal activity against MRSA.
- Aspartate transcarbamoylase (ATCase), crucial for pyrimidine synthesis, was identified as the specific target of Py-27.
- Py-27 inhibits ATCase, disrupting pyrimidine synthesis, DNA replication, and leading to oxidative damage.
- Py-27 eradicated mature MRSA biofilms, showed low resistance development, and favorable toxicology.
- In vivo studies showed Py-27 outperformed vancomycin in resolving MRSA infections and promoting tissue repair.
Conclusions:
- Py-27 represents a promising new therapeutic candidate for MRSA infections.
- Targeting ATCase with pyrazole-amide compounds offers a viable strategy against MRSA.
- The findings support the development of novel antimicrobials disrupting essential metabolic pathways.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Gene Regulation in Microbial Communities: Quorum Sensing
